Home › Funds › Wellington Management Group › CVS
Wellington Management Group position in CVS
CVS HEALTH CORP · Consumer Staples
Wellington Management Group reported holding 36,682,829 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$3.14B, representing 0.62% of its reported portfolio and ranking #25 among its reported holdings. Wellington Management Group has disclosed CVS holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Wellington Management Group's CVS position evolved
Wellington Management Group first disclosed a stake in CVS in Q3 2021 at 8,099,754 shares (US$687.3M). The position peaked in Q2 2026 at 33,801,113 shares, worth US$3.50B. Across 21 filings, Wellington Management Group increased the stake 10 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 36,682,829 shares valued at US$3.14B — an increase of 2,881,716 shares quarter over quarter.. Notable position changes include a 219% increase in Q2 2025 (shares rose 10% over the following quarter), a 392% increase in Q3 2025 (shares rose 6% over the following quarter), a 193% increase in Q4 2025 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 8.10M | $687.35M | New |
| Q4 2021 | 9.93M | $1.02B | Add |
| Q1 2022 | 8.52M | $862.03M | Reduce |
| Q2 2022 | 8.36M | $774.82M | Reduce |
| Q3 2022 | 7.46M | $711.16M | Reduce |
| Q4 2022 | 3.29M | $306.32M | Reduce |
| Q1 2023 | 2.90M | $215.66M | Reduce |
| Q2 2023 | 2.74M | $189.21M | Reduce |
| Q3 2023 | 164.41K | $11.48M | Reduce |
| Q4 2023 | 219.03K | $17.29M | Add |
| Q1 2024 | 210.42K | $16.78M | Reduce |
| Q2 2024 | 211.13K | $12.47M | Hold |
| Q3 2024 | 224.25K | $14.10M | Add |
| Q4 2024 | 220.13K | $9.88M | Reduce |
| Q1 2025 | 403.37K | $27.33M | Add |
| Q2 2025 | 1.29M | $88.84M | Add |
| Q3 2025 | 6.33M | $477.27M | Add |
| Q4 2025 | 18.56M | $1.47B | Add |
| Q1 2026 | 22.57M | $1.62B | Add |
| Q2 2026 | 33.80M | $3.50B | Add |
| Q3 2026 | 36.68M | $3.14B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 28 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$6.35B), Capital World Investors (US$6.35B), DODGE & COX (US$3.95B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.04M sh · $6.35B · Q3 2026
- Capital World Investors 74.04M sh · $6.35B · Q3 2026
- DODGE & COX 46.04M sh · $3.95B · Q3 2026
- Dodge & Cox 46.04M sh · $3.95B · Q3 2026
- WELLINGTON MANAGEMENT GROUP LLP 36.68M sh · $3.14B · Q3 2026
- DAVIS SELECTED ADVISERS 11.90M sh · $1.02B · Q3 2026
- Pzena Investment Management 10.30M sh · $882.34M · Q3 2026
More on Wellington Management Group
FAQ
How long has Wellington Management Group held CVS?
Wellington Management Group has disclosed CVS holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is Wellington Management Group's current position in CVS?
As of Q3 2026, Wellington Management Group holds 36.68M shares of CVS (CVS HEALTH CORP), valued at $3.14B, representing 0.62% of its reported portfolio and ranking #25.
Has Wellington Management Group been buying or selling CVS?
In the latest 13F filing (Q3 2026), Wellington Management Group increased its position in CVS. The position peaked in Q2 2026 at 33.80M shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, DODGE & COX, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.